Navigation Links
Standard Methods Miss 50% of Pharmaceutical Key Opinion Leaders
Date:1/28/2010

Social Network Analysis of 11 disease areas shows that current KOL identification methods produce inaccurate results; relationship models are more effective than bibliometric lists in measuring KOL impact

(PRWEB) January 28, 2010 -- A new white paper challenges the generally-held notion that scientists who are “productive” in terms of publishing are well connected and meaningful to the community. Research firm Lnx Pharma found that in a large number of cases, the opposite was true.

This study questions the current methodology used extensively in pharmaceutical and biotech industries to find Key Opinion Leaders (KOLs) and influential thought leaders. KOLs are a key part of pharmaceutical marketing, discovery and development stages.

“Companies typically use a combination of personal referrals plus standard bibliometrics to find and evaluate candidates for advocacy and advisory roles in drug development,” said Philip Topham, General Manager of Lnx Pharma. “They consider it to be more of an art form than science - qualitative information is layered with publishing counts and speaking engagements data in order to judge the potential value of KOLs. We can now quantify that this methodology is leaving a large number of truly respected thought leaders out of the consideration set.”

Lnx Pharma research shows that bibliometrics as a means of discovering and ranking potential product advocates fails to find over 50% of the truly respected experts, compared to using the more advanced Large Scale Social Network Analysis (SNA). Lnx Pharma is a research company that uses SNA to help pharmaceutical companies to map thought leadership and marketing strategies.

The LS-SNA method was used to evaluate more than 20 different disease state areas including:
        

 
  • Obesity
  •         
  • Blood Coagulation Disorders
  •         
  • Infectious Diseases
  •         
  • Autism
  •         
  • Cardiology
  •         
  • Oncology - Breast
  •         
  • Oncology - Lung
  •         
  • Oncology - Ovarian
  •         
  • Oncology - Colorectal
  •         
  • Rheumatology
  •         
  • Central Nervous System
  •         
  • Diagnostics & Biomarkers
  •         
  • Insomnia
  •         
  • Diabetes
The complex relationships between researchers contain a wealth of information that can be extracted using Large Scale Social Network Analysis. Consequently it is only natural to use research publications to identify experts or key opinion leaders (KOLs.) Yet for all the wealth of information, no amount of counting publications will determine “respect.” A person could publish 10 times or 100 times and still not be respected. And yet, companies continue to utilize this outdated an ineffective technique.

The full white paper may be downloaded from the Lnx Pharma website: http://bit.ly/whitepaper6

About Lnx Pharma
Lnx Pharma is a division of Lnx Research, LLC a privately held company based in Irvine, California, dedicated to leadership in the analysis of knowledge-creating communities. Lnx Research utilizes proprietary social network analysis methods and technologies to identify and understand "The Invisible College" of key opinion leaders in order to answer questions about knowledge communities for government and commercial clients in multiple industries. For white papers on this topic, or more specific information on Lnx Pharma, email info(at)lnxpharma(dot)com, or see http://www.lnxpharma.com.

# # #

Read the full story at http://www.prweb.com/releases/pharmaceutical-marketing/kol-management/prweb3538204.htm.


'/>"/>
Source: PRWeb
Copyright©2010 Vocus, Inc.
All rights reserved  

Related medicine news :

1. Majority of 2.4 Million U.S. Children With ADHD Not Diagnosed or Consistently Treated, According to New Gold Standard Study by Cincinnati Childrens Researchers
2. Standard Management Announces OTCBB Listing
3. Gastroenterology sets standards for CT colonography
4. Public Health and Need for Consistent Standards Preclude Exception for Breastfeeding Mother in National Medical Licensing Test
5. New Drug No Substitute for Standard Blood-Clot Therapy
6. National Quality Forum Issues First Consensus Standards for the Treatment of Substance Use Conditions
7. New guidelines set to improve standard of cows milk allergy care
8. Green Seal Ramps Up Environmental Standard for Household Cleaners
9. URAC CEO Testifies Before New Hampshire Legislators Regarding New URAC Standards for Pharmacy Benefit Management
10. Standard treatment for prostate cancer may encourage spread of disease
11. Health Literacy Innovations Releases New Survey on Medicaid Health Literacy Standards
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Standard Methods Miss 50% of Pharmaceutical Key Opinion Leaders 
(Date:6/25/2016)... ... June 25, 2016 , ... As a lifelong Southern Californian, Dr. Omkar Marathe ... from the David Geffen School of Medicine at UCLA. He trained in Internal Medicine ... his fellowship in hematology/oncology at the UCLA-Olive View-Cedars Sinai program where he had the ...
(Date:6/25/2016)... ... June 25, 2016 , ... Conventional wisdom preaches the benefits of moderation, whether ... latter, setting the bar too high can result in disappointment, perhaps even self-loathing. However, ... their goal. , Research from PsychTests.com reveals that behind the tendency ...
(Date:6/24/2016)... , ... June 24, 2016 , ... June 19, 2016 ... dangers associated with chronic pain and the benefits of holistic treatments, Serenity Recovery ... are suffering with Sickle Cell Disease. , Sickle Cell Disease (SCD) is a disorder ...
(Date:6/24/2016)... Fla. (PRWEB) , ... June 24, 2016 , ... Global ... Trend magazine’s 2016 Legal Elite. The attorneys chosen by their peers for this recognition ... Florida. , Seven Greenberg Traurig Shareholders received special honors as members of this year’s ...
(Date:6/24/2016)... ... 2016 , ... Topical BioMedics, Inc, makers of Topricin and MyPainAway Pain Relief Products, join The ... raise to $12 an hour by 2020 and then adjusting it yearly to increase at ... the minimum wage, assure the wage floor does not erode again, and make future increases ...
Breaking Medicine News(10 mins):
(Date:6/26/2016)... 27, 2016  VMS Rehab Systems, Inc. ( www.vmsrehabsystemsinc.com ... whatever measures required to build a strong and stable ... currently listed on the OTC Markets-pink current trading platform. ... CEO, "We are seeing an anomaly in market trading ... only by the Company, but shareholders and market players ...
(Date:6/24/2016)... , June 24, 2016  Consumers have ... and regulators/payers have placed more emphasis on patient ... patient support programs in the pharmaceutical industry have ... medications. Consequently, pharmaceutical companies are focusing on becoming ... are providing products and services that improve health. ...
(Date:6/24/2016)... , June 24, 2016  Global Blood ... biopharmaceutical company developing novel therapeutics for the treatment ... today announced the closing of its previously announced ... stock, at the public offering price of $18.75 ... offering were offered by GBT. GBT estimates net ...
Breaking Medicine Technology: